CLASS II ONGOING Device recall · Reported 11 Nov 2026 · FDA Enforcement Report

Senographe Pristina recalled by GE Medical Systems

GE Medical Systems is recalling Senographe Pristina. The recall was initiated on 28 Aug 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesGTIN(s): 00840682118460, 00840682142052, 00840682145879, 00195278022745, 00195278276971, 00195278661999, 00195278665379, 00195278914026, 00198953109281, 10198953054311, 10195278901764.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0327-2027
FDA event ID
100070
Recalling firm
GE Medical Systems, Waukesha, WI
Classification
Class II
Status
Ongoing
Recall initiated
28 Aug 2026
FDA classified
4 Nov 2026
Reported
11 Nov 2026
Type
FDA Mandated
Reason category
Other Reasons

Timeline

28 Aug 2026Recall initiated by company
4 Nov 2026Classified by FDA+68 days
11 Nov 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

GE HealthCare has become aware of a nonconformance to certain Senographe Pristina VIA systems. Specifically, in cases of 3D+2D manual mode where the acquisition configuration of the anode track/filter combination is different, it can result in the following: the collimator blades might be visible in the image, or the collimator might be open more than expected, and an incorrect collimator filter might be used with respect to the anode track selected This issue could result in a minor additional X-ray dose being delivered to the patient and obvious artifacts in the image (collimator blades).

Product as listed by the FDA

Senographe Pristina

Where it was distributed

USA and OUS.

Questions about this recall

Why was it recalled?

GE HealthCare has become aware of a nonconformance to certain Senographe Pristina VIA systems. Specifically, in cases of 3D+2D manual mode where the acquisition configuration of the anode track/filter combination is different, it can result in the following: the collimator blades might be visible in the image, or the collimator might be open more than expected, and an incorrect collimator filter might be used with respect to the anode track selected This issue could result in a minor additional X-ray dose being delivered to the patient and obvious artifacts in the image (collimator blades).

Which lots are affected?

GTIN(s): 00840682118460, 00840682142052, 00840682145879, 00195278022745, 00195278276971, 00195278661999, 00195278665379, 00195278914026, 00198953109281, 10198953054311, 10195278901764.

Where was it sold?

USA and OUS.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 17 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 100070

More recalls from GE Medical Systems

All 163

Other Other Medical Devices recalls

All 13,985